2c68: Difference between revisions

Revision as of 22:04, 12 November 2007

CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR

OverviewOverview

Crystallographic and modelling data, in conjunction with a medicinal, chemistry template-hopping approach, led to the identification of a series, of novel and potent inhibitors of human cyclin-dependent kinase 2 (CDK2), with selectivity over glycogen synthase kinase-3beta (GSK-3beta). One, example had a CDK2 IC(50) of 120 nM and showed selectivity over GSK-3beta, of 167-fold.

About this StructureAbout this Structure

2C68 is a Single protein structure of sequence from Homo sapiens with CT6 as ligand. Active as Transferred entry: 2.7.11.1, with EC number 2.7.1.37 Structure known Active Site: AC1. Full crystallographic information is available from OCA.

ReferenceReference

Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR., Richardson CM, Williamson DS, Parratt MJ, Borgognoni J, Cansfield AD, Dokurno P, Francis GL, Howes R, Moore JD, Murray JB, Robertson A, Surgenor AE, Torrance CJ, Bioorg Med Chem Lett. 2006 Mar 1;16(5):1353-7. Epub 2005 Dec 1. PMID:16325401

Page seeded by OCA on Mon Nov 12 21:11:21 2007

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

Revision as of 18:54, 5 November 2007 view source OCA (talk \| contribs) Bots, Bureaucrats, Administrators 3,175,590 edits No edit summary ← Older edit		Revision as of 22:04, 12 November 2007 view source OCA (talk \| contribs) Bots, Bureaucrats, Administrators 3,175,590 edits No edit summary Newer edit →
Line 33:		Line 33:
	[[Category: triazolopyrimidine inhibitor]]		[[Category: triazolopyrimidine inhibitor]]

	''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov ~~5 18~~:00:07 2007''		''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 21:11:21 2007''